Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protect... ( New size allows for treatment of sma...)

Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System

Date:5/19/2008

New size allows for treatment of smaller-diameter diseased saphenous vein

grafts

NATICK, Mass., May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its FilterWire EZ(TM) Embolic Protection System in a new 2.25 - 3.5 mm size, designed to contain and remove embolic material that may be dislodged during an interventional saphenous vein graft (SVG) procedure; otherwise, embolic material may travel into the microvasculature where it could pose an increased risk for a heart attack. The Company said the product would be available immediately.

"Recently revised treatment guidelines by the American College of Cardiology have recommended the use of embolic protection devices when treating patients with SVG disease(1)," said Hank Kucheman, Senior Vice President and Group President, Cardiovascular for Boston Scientific. "Until now, a filter-based solution smaller than 3.0 mm was not available for SVGs, which meant a significant patient population went underserved. By introducing this smaller size, Boston Scientific now makes it possible for physicians to meet this standard of care in a broader range of SVG vessels."

The FilterWire EZ System is a low-profile embolic protection device that has been clinically proven to capture and remove embolic material, leading to reduced complications during balloon angioplasty and stenting procedures in SVGs(2). SVG disease occurs in patients who have previously had coronary artery bypass graft (CABG) surgery in which a vessel harvested from the patient's leg is surgically attached to the arteries of the heart. Blood is redirected through the surgically attached SVG, bypassing the blocked artery and increasing
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Boston Scientific Announces FDA Approval of New Heart Failure Lead
2. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
3. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
4. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
5. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
6. Fraunhofer and Boston University Hosted Prestigious SME Tour
7. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
8. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
9. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
10. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement

Post Your Comments:

Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protect...( New size allows for treatment of sma...)